LENSCALE .05 g/mL
ATRIPLEX LENTIFORMIS POLLEN · INJECTION, SOLUTION · ALK-Abello, Inc.
LENSCALE is a injection, solution containing atriplex lentiformis pollen at .05 g/mL, taken percutaneous. Manufactured by ALK-Abello, Inc..
Key Facts
- Brand Name
- LENSCALE
- Generic Name
- ATRIPLEX LENTIFORMIS POLLEN
- NDC Code (Product)
0268-1482- Manufacturer
- ALK-Abello, Inc.
- Strength
- .05 g/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- PERCUTANEOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA103753
- Marketing Start
- 01/01/1965
Recall History
No Recall HistoryFrequently Asked Questions
What is LENSCALE used for?
LENSCALE contains ATRIPLEX LENTIFORMIS POLLEN. It is a injection, solution taken percutaneous. Consult your doctor for specific uses.
Is LENSCALE a controlled substance?
LENSCALE is not classified as a controlled substance by the DEA.
What is the generic name for LENSCALE?
The generic name for LENSCALE is ATRIPLEX LENTIFORMIS POLLEN. There are no other listed brand versions of ATRIPLEX LENTIFORMIS POLLEN.
What is the NDC code for LENSCALE .05 g/mL?
The NDC (National Drug Code) for LENSCALE .05 g/mL is 0268-1482, listed by ALK-Abello, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)